上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2014年
19期
20-23
,共4页
拉莫三嗪%双相情感障碍%治疗应用%安全性
拉莫三嗪%雙相情感障礙%治療應用%安全性
랍막삼진%쌍상정감장애%치료응용%안전성
lamotrigine%bipolar disorder%treatment application%security
拉莫三嗪作为心境稳定剂治疗双相情感障碍已经应用于临床。在2013年最新的CANMAT指南中新增了拉莫三嗪单药或联合其他药物的治疗方案，提示目前应用拉莫三嗪治疗双相情感障碍已受到广泛关注。本文综述了近几年拉莫三嗪在治疗双相情感障碍各亚型中的临床研究、安全性及应用前景，为双相障碍的治疗提供新观点及新思路。
拉莫三嗪作為心境穩定劑治療雙相情感障礙已經應用于臨床。在2013年最新的CANMAT指南中新增瞭拉莫三嗪單藥或聯閤其他藥物的治療方案，提示目前應用拉莫三嗪治療雙相情感障礙已受到廣汎關註。本文綜述瞭近幾年拉莫三嗪在治療雙相情感障礙各亞型中的臨床研究、安全性及應用前景，為雙相障礙的治療提供新觀點及新思路。
랍막삼진작위심경은정제치료쌍상정감장애이경응용우림상。재2013년최신적CANMAT지남중신증료랍막삼진단약혹연합기타약물적치료방안，제시목전응용랍막삼진치료쌍상정감장애이수도엄범관주。본문종술료근궤년랍막삼진재치료쌍상정감장애각아형중적림상연구、안전성급응용전경，위쌍상장애적치료제공신관점급신사로。
Lamotrigine as a mood stabilizer for the treatment of bipolar disorder has been used in clinical. The treatment programs of lamotrigine monotherapy or in combination with other drugs were added into the latest CANMAT guide in 2013, which indicated that the application of lamotrigine in the treatment of bipolar disorder is widely concerned. This review describes the clinical study, safety and the application prospect of lamotrigine in the treatment of some kinds of bipolar disorder subtypes so as to provide novel perspectives and new ideas for the treatment of bipolar disorder.
